Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Antengene Enters into a Global Clinical Collaboration with MSD to Evaluate ATG-037 (CD73 Inhibitor) in Combination with KEYTRUDA® (pembrolizumab) 2022-12-27 08:30
Superior Neutralizing Antibody Titer Levels Against Omicron BF.7 And BA.2.75 Of The Company's Two-Component Recombinant COVID-19 Vaccine ReCOV As Compared To International Mainstream mRNA Vaccine 2022-12-26 11:33
Fosun International Granted Three Awards from Global Banking and Finance Review in the United Kingdom 2022-12-23 10:52
JUNIPER BIOLOGICS WINS M&A AWARD 2022 BY ACQUISITION INTERNATIONAL 2022-12-23 09:35
Everest Medicines' Licensing Partner Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis 2022-12-22 08:00
ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances 2022-12-22 06:04
CGTN: 'New Approaches': How China stepped up its COVID-19 treatments 2022-12-21 18:51
Medidata awarded International Innovation Award for Medidata Sensor Cloud 2022-12-21 14:44
Ascletis' NASH Drug ASC41(THRβ) Phase II Enrollment is Progressing as Planned 2022-12-21 08:00
Sirnaomics Announces Interim Data from Phase I Clinical Trial of RNAi Therapeutic STP707 for Treatment of Multiple Solid Tumors 2022-12-21 00:39
AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi 2022-12-20 23:16
Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia 2022-12-20 20:00
Carrick Therapeutics and The Menarini Group Announce Clinical Trial Collaboration to Evaluate Samuraciclib and Elacestrant Combination 2022-12-19 23:07
Ascletis Announces Notice of Issuance of the U.S. Patent for Oral Viral Polymerase Inhibitor ASC10 and Its Derivatives 2022-12-19 18:10
Clinical Trial Approval For The Company's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines 2022-12-19 13:53
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology 2022-12-16 19:56
Novavax Announces Pricing of $65 Million Public Offering of Common Stock 2022-12-16 14:49
Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes 2022-12-16 14:18
Bioved Pharmaceuticals, Inc. announces the results of its Phase III Randomized Clinical Trial in Moderate Covid-19 with Artovid-20®, a natural plant-based oral product 2022-12-16 01:30
Nevisense for skin barrier evaluation included in large Australian birth cohort study 2022-12-15 15:50
1 49 50 51 52 53 228